title: From GWAS to clinical utility in Parkinson's disease.
authors.affiliation: Section of Clinical and Molecular Neurogenetics, Department of Neurology, University of Lübeck, 23538 Lübeck, Germany. christine.klein@neuro.uni-luebeck.de
authors.forename: Christine
authors.initials: C
authors.lastname: Klein
authors.forename: Andreas
authors.initials: A
authors.lastname: Ziegler
mesh_terms: D030342:Genetic Diseases, Inborn / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D030661:Genetic Privacy / Q000941:ethics; D005820:Genetic Testing / Q000941:ethics; D055106:Genome-Wide Association Study; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D010300:Parkinson Disease / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D018570:Risk Assessment; D051844:alpha-Synuclein / Q000235:genetics
chemical_list: C497604:SNCA protein, human; D051844:alpha-Synuclein; C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases